Just wondering - what would be the main reason(s) why the FDA should not approve Zircaix?
I am a small cap investor from Germany. I do not know much about Telix, aside that they appear to do a great job looking at the shareprice. I stumbled upon Telix while researching a German company called Heidelberg Pharma from which Telix inlicensed the antibody used in Zircaix. Heidelberg Pharma is entiteld to receive royalties from Telix (20% of Zircaix product sales if I am not mistaken). They did a partial sale of there royalty stream for Zircaix and would receive USD 75m upon Zircaix FDA approval.
PR: Heidelberg Pharma Announces Royalty Financing Agreement with HealthCare Royalty for up to USD 115 million - Heidelberg Pharma AG (heidelberg-pharma.com)
Heidelberg Pharma trading at an Mcap of just EUR 120m, EV < 100m. The market appears to price in a high risk of Zircaix not receiving FDA approval.
Happy to hear your thoughts!
Disclosure: I hold a position in Heidelberg Pharma.
- Forums
- ASX - By Stock
- TLX
- Ann: Telix Completes TLX250-CDx (Zircaix) BLA Submission
Ann: Telix Completes TLX250-CDx (Zircaix) BLA Submission, page-34
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TLX (ASX) to my watchlist
|
|||||
Last
$19.69 |
Change
-0.315(1.58%) |
Mkt cap ! $6.692B |
Open | High | Low | Value | Volume |
$20.47 | $20.76 | $19.68 | $11.89M | 586.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 222 | $19.67 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.69 | 483 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 402 | 19.940 |
5 | 509 | 19.920 |
9 | 663 | 19.910 |
9 | 2700 | 19.900 |
6 | 428 | 19.890 |
Price($) | Vol. | No. |
---|---|---|
19.950 | 295 | 6 |
19.960 | 813 | 8 |
19.970 | 839 | 11 |
19.980 | 423 | 6 |
19.990 | 362 | 5 |
Last trade - 10.38am 18/07/2024 (20 minute delay) ? |
Featured News
TLX (ASX) Chart |